{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:02:23Z","timestamp":1773378143498,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2020R1G1A1099654"],"award-info":[{"award-number":["NRF-2020R1G1A1099654"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jcyt.2023.07.005","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T16:19:02Z","timestamp":1691165942000},"page":"1307-1316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-8200","authenticated-orcid":false,"given":"Youngwoo","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi June","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2845-2933","authenticated-orcid":false,"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-2050","authenticated-orcid":false,"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-6616","authenticated-orcid":false,"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-9814","authenticated-orcid":false,"given":"Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2949-4166","authenticated-orcid":false,"given":"Jong-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-4839","authenticated-orcid":false,"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcyt.2023.07.005_bib0001","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00277-019-03694-y","article-title":"First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients","volume":"98","author":"Janikova","year":"2019","journal-title":"Ann Hematol"},{"issue":"20","key":"10.1016\/j.jcyt.2023.07.005_bib0002","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1158\/1078-0432.CCR-14-2020","article-title":"Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice","volume":"20","author":"O'Connor","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdx787","article-title":"Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers","volume":"29","author":"Fossard","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jcyt.2023.07.005_bib0004","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1038\/bcj.2016.63","article-title":"First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation","volume":"6","author":"Wilhelm","year":"2016","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.jcyt.2023.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.31861","article-title":"The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study","volume":"125","author":"Park","year":"2019","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.jcyt.2023.07.005_bib0006","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d'Amore","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2023.07.005_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12185-018-2560-x","article-title":"Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma","volume":"109","author":"Yamasaki","year":"2019","journal-title":"International journal of hematology"},{"issue":"1","key":"10.1016\/j.jcyt.2023.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1705668","article-title":"Viral purging of haematological autografts: should we sneeze on the graft?","volume":"40","author":"Thirukkumaran","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2023.07.005_bib0009","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbmt.2007.05.012","article-title":"Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission","volume":"13","author":"Brown","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/annonc\/mdh090","article-title":"Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study","volume":"15","author":"Belhadj","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcyt.2023.07.005_bib0011","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703515","article-title":"Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL","volume":"29","author":"Flohr","year":"2002","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1016\/j.jcyt.2023.07.005_bib0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjh.12664","article-title":"Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma","volume":"164","author":"Yahng","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.07.005_bib0013","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2141.2005.05827.x","article-title":"Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device","volume":"132","author":"van Heeckeren","year":"2006","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jcyt.2023.07.005_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/152581600419242","article-title":"CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device","volume":"9","author":"Despres","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"issue":"12","key":"10.1016\/j.jcyt.2023.07.005_bib0015","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood.V91.12.4489","article-title":"Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma","volume":"91","author":"Tricot","year":"1998","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2023.07.005_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hon.2399","article-title":"The 2016 updated WHO classification of lymphoid neoplasias","volume":"35","author":"Quintanilla-Martinez","year":"2017","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2023.07.005_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1827.2007.02195.x","article-title":"Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases","volume":"58","author":"Karube","year":"2008","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.jcyt.2023.07.005_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/bmt.2012.129","article-title":"The role of hematopoietic SCT in adult Burkitt lymphoma","volume":"48","author":"Ahmed","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"27","key":"10.1016\/j.jcyt.2023.07.005_bib0019","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.07.005_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14653240310000083","article-title":"Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study","volume":"5","author":"Gratama","year":"2003","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0021","first-page":"603","article-title":"Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS)","volume":"18","author":"Martin-Henao","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2023.07.005_bib0022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12967-017-1330-5","article-title":"GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Tittlbach","year":"2017","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0023","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3904\/kjim.2015.30.3.362","article-title":"Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients","volume":"30","author":"Yoon","year":"2015","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0024","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2023.07.005_bib0025","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1200\/JCO.1996.14.9.2454","article-title":"Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry","volume":"14","author":"Williams","year":"1996","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.jcyt.2023.07.005_bib0026","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","article-title":"Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma","volume":"325","author":"Gribben","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0027","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/bmt.2008.318","article-title":"Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma","volume":"43","author":"Ho","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0028","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","article-title":"High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up","volume":"18","author":"Apostolidis","year":"2000","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jcyt.2023.07.005_bib0029","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2023.07.005_bib0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2008-05-160200","article-title":"High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years","volume":"113","author":"Gyan","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2023.07.005_bib0031","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","article-title":"High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"100","author":"Ladetto","year":"2002","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.jcyt.2023.07.005_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/beha.1999.0008","article-title":"Positive selection of autologous peripheral blood stem cells","volume":"12","author":"Lopez","year":"1999","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1016\/j.jcyt.2023.07.005_bib0033","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2004.05144.x","article-title":"Bone marrow histopathology in peripheral T-cell lymphomas","volume":"127","author":"Dogan","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jcyt.2023.07.005_bib0034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12185-018-2407-5","article-title":"NK cell therapy for hematologic malignancies","volume":"107","author":"Mehta","year":"2018","journal-title":"International journal of hematology"},{"issue":"1","key":"10.1016\/j.jcyt.2023.07.005_bib0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10428194.2015.1045897","article-title":"The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"57","author":"Beltran","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.jcyt.2023.07.005_bib0036","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jcyt.2013.05.014","article-title":"Depletion of T-cell receptor alpha\/beta and CD19 positive cells from apheresis products with the CliniMACS device","volume":"15","author":"Schumm","year":"2013","journal-title":"Cytotherapy"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923010058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923010058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:49:51Z","timestamp":1761443391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923010058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1465324923010058"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.07.005","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}